India IP Litigation
7,068 annotated decisions
Page 133 of 295 · 7,068 total
Trex India Pvt. Ltd. v.Cde Asia Limited
The dispute originated from a suit for permanent injunction filed by Cde Asia Limited against Trex India Pvt. Ltd. regarding alleged infringement of its Patent No. 3072491 and Design No. 2626292 concerning the product 'FM 120 CONEXUS'. The present appeal challenged the Single Judge's order, but the High Court dismissed the appeal on a preliminary objection regarding its maintainability under the Commercial Courts Act.
S. N. Biri Factory Private Limited v.Mukesh Chand Khandelwal & Anr.
The Delhi High Court addressed a dispute concerning artistic works used in matchstick branding, where the Petitioner alleged that Respondent No. 1's new copyright was deceptively similar to their existing registered designs and trademarks. Despite the Deputy Registrar of Copyrights initially rejecting the objection, the Court found prima facie evidence suggesting imitation of unique features and misappropriation of phrases like 'शहे नशाह मािचस NO. 99'. Consequently, the High Court granted a stay on the effect of the impugned copyright registration while the matter proceeds.
Leeford Healthcare Limited v.Vobb Healthcare & Ors.
The Delhi High Court granted an ad-interim injunction in favor of Leeford Healthcare Limited against Vobb Healthcare & Ors. The court found a prima facie case of trademark infringement and passing off, specifically concerning the medicinal cream brand 'DERMIFORD.' Given that the goods are pharmaceutical and the defendants had recently entered the market, the court held that Leeford would suffer grave injury without immediate protection. This order temporarily halts the defendants from using deceptively similar marks like 'NEO DERMIFORD' until further orders.
L'Oreal S.A. v.Tarun Sankhla trading as M/s LEORA COSMETICS
L'Oreal S.A. filed a suit seeking permanent injunction against Tarun Sankhla (trading as M/s LEORA COSMETICS) for infringing its trademarks, passing off, and diluting its brand reputation in the cosmetics market. The court found that the defendant was using deceptively similar marks and tradenames, leading to the decreeing of the plaintiff's suit.
Puma Se v.Naveen Sikka And Anr
The Delhi High Court allowed Puma Se's petition to cancel a specific trademark registered by Naveen Sikka and Anr. The judgment followed a settlement agreement reached between the parties, which was found to be lawful. Consequently, the court ordered the removal of the impugned mark from the Register of Trade Marks in Class 9.
M/S.Mahavir Pvc Cables Factory v.M/S.Indo Mahaveer Kable
The Orissa High Court granted a temporary injunction in favor of M/S. Mahavir PVC Cables Factory against M/S. Indo Mahaveer Kable. The court found that the Respondent's use of 'INDO MAHAVEER KABLE' was phonetically and visually deceptive to the Plaintiff’s reputed trade mark, 'MAHAVIR'. Crucially, the court also considered the public interest, noting that the Defendant was using sub-standard materials in their products, thereby protecting consumers from potential harm. This ruling reinforces the importance of preventing market confusion and ensuring consumer safety when dealing with trademark disputes.
Cellresearch Corporation Pte Ltd v.Controller Of Patents And Designs
The appeal challenges an order rejecting Cellresearch Corporation's divisional patent application (No. 10875/DELNP/2013) based on lack of distinct invention from its parent application (No. 1492/DELNP/2007). The appellant argues that the rejection is invalid because the objections raised in the parent application had already been complied with.
Janssen Pharmaceuticals Inc And Others v.Clevus Lifesciences and others
The plaintiffs, exclusive licensees of the patent holder for Indian Patent No. 232231, filed a suit alleging infringement by defendant No. 1 and others who were manufacturing and offering Canagliflozin tablets under brand names like Adkana. The court found a prima facie case in favor of the plaintiffs.
M/s.Fair Beat Herbals Cosmetics Private Ltd. v.The Registrar of Trademarks
The Madras High Court addressed writ petitions challenging trademark registration proceedings involving 'Fair Beat'. The court noted that objections had been raised against the application, and an inquiry was pending before the Trademark Registry. Consequently, the High Court directed the Registrar of Trademarks to conduct a thorough enquiry, ensuring all parties are given an opportunity to participate, and to pass final orders on the merits as quickly as possible.
Boehringer Ingelheim Pharma Gmbh & Co. v.Vee Excel Drugs And Pharmaceuticals Private Ltd.
Boehringer Ingelheim Pharma filed multiple suits seeking permanent injunction against generic drug manufacturers, including Vee Excel Drugs, alleging infringement of Indian Patent No. IN 243301 related to Linagliptin compounds. The Delhi High Court examined the applications for interim injunction across all connected matters. The court found that the patent was vulnerable to revocation due to prior claiming and noted attempts at evergreening by the patentees. Consequently, the plaintiffs failed to establish a prima facie case, leading to the dismissal of all interim injunction applications.
Boehringer Ingelheim Pharma Gmbh & Co. v.Vee Excel Drugs And Pharmaceuticals Private Ltd.
This judgment addresses multiple suits filed by Boehringer Ingelheim Pharma against various Indian pharmaceutical companies, seeking permanent injunctions against infringing Patent No. IN 243301 related to Linagliptin tablets. The Delhi High Court examined the prima facie case and found that the patent was vulnerable to revocation due to prior claiming and attempts at evergreening by the plaintiffs. Consequently, the court dismissed all applications for interim injunction, allowing defendants to manufacture and sell products containing Linagliptin as the active pharmaceutical ingredient.
Intex Technologies (India) Ltd v.Telefonaktiebolaget L M Ericsson (Pub)
This Delhi High Court judgment addressed cross-appeals concerning the validity and infringement of Standard Essential Patents (SEPs) related to telecom technology. The court affirmed that Ericsson's patents were prima facie essential and infringed, finding Intex to be an unwilling licensee. Despite arguments regarding SEPs being unknown in Indian law, the court upheld the necessity of FRAND compliance to ensure parity with global implementers.
Ifp Energies Nouvelles v.The Assistant Controller of Patents and Designs, Government of India
Ifp Energies Nouvelles appealed the rejection of its patent application (No. 1373/CHE/2015) by the Controller of Patents and Designs, Chennai. The appellant argued that the rejection order was non-speaking and failed to consider their submissions or prior acceptance in the USA. The High Court agreed, finding that the material contentions were ignored.
Boehringer Ingelheim Pharma Gmbh And Co. Kg & Anr. v.Alkem Laboratories Ltd & Anr., Vee Excel Drugs and Pharmaceuticals Private Ltd. & Ors., Micro Labs Limited, Natco Pharma Limited & Anr., Mankind Pharma Limited
This judgment addresses multiple suits filed by Boehringer Ingelheim Pharma against various Indian pharmaceutical companies seeking permanent injunctions for infringing Patent No. IN 243301, which covers Linagliptin compounds. The Delhi High Court found that the plaintiffs failed to establish a prima facie case for granting interim relief. Furthermore, the court expressed concern regarding the patent's vulnerability due to prior claiming and alleged attempts at 'evergreening.' Consequently, all applications for injunction were dismissed, allowing defendants to continue manufacturing and selling products containing Linagliptin.
Boehringer Ingelheim Pharma Gmbh And Co. Kg & Anr. v.Vee Excel Drugs and Pharmaceuticals Private Ltd. & Ors., Alkem Laboratories Ltd & Anr., Micro Labs Limited, Natco Pharma Limited & Anr., Mankind Pharma Limited
Boehringer Ingelheim Pharma sought permanent injunctions against various Indian pharmaceutical companies, alleging infringement of Patent No. IN 243301 related to Linagliptin tablets. The Delhi High Court examined the applications for interim injunction across multiple connected suits. The court found that the plaintiffs failed to establish a prima facie case, noting concerns about potential patent vulnerability due to prior claiming and attempts at evergreening. Consequently, all interim injunction applications were dismissed, allowing defendants to continue manufacturing and selling the products.
Boehringer Ingelheim Pharma Gmbh And Co. Kg & Anr. v.Mankind Pharma Limited
Boehringer Ingelheim Pharma filed multiple suits seeking permanent injunction against Indian pharmaceutical companies for allegedly infringing Patent No. IN 243301, which covers Linagliptin compounds. The Delhi High Court examined the applications for interim injunction across all connected matters. The court found that the suit patent was vulnerable to revocation due to prior claiming and noted attempts by the plaintiffs towards 'evergreening.' Consequently, the court dismissed all applications for interim injunction, allowing defendants to manufacture and sell products containing Linagliptin.
Telefonaktiebolaget Lm Ericsson (Pub) v.Intex Technologies (India) Limited
This Delhi High Court judgment addressed a complex dispute involving Standard Essential Patents (SEPs) between Ericsson and Intex. The court examined whether the patents were essential, if Intex was infringing them, and if Intex had acted as an unwilling licensee despite Ericsson's FRAND commitments. Ultimately, the court found that the patents were prima facie valid and infringed, compelling Intex to pay the full royalty amount.
Boehringer Ingelheim Pharma Gmbh And Co. Kg & Anr. v.Vee Excel Drugs and Pharmaceuticals Private Ltd. & Ors., Alkem Laboratories Ltd & Anr., Micro Labs Limited, Natco Pharma Limited & Anr., Mankind Pharma Limited
This judgment addresses multiple suits filed by Boehringer Ingelheim Pharma seeking permanent injunction against various Indian pharmaceutical companies for infringing Patent No. IN 243301, which covers Linagliptin compounds. The court examined the applications for interim injunction and found that the plaintiffs failed to establish a prima facie case. Furthermore, the judge expressed concerns regarding the patent's vulnerability due to prior claiming and alleged attempts at evergreening by the patentees. Consequently, all interim injunction applications were dismissed, allowing the defendants to continue manufacturing and selling products containing Linagliptin.
Diamond Star Global Sdn. Bhd. v.Joint Controller Of Patents And Designs
The appellant sought a patent for 'Hygiene Wash,' a skin care preparation using wood vinegar derived from the Rhizophora apiculata tree. The Controller rejected the application, but the High Court found that the invention possessed an inventive step by identifying guaiacol-free wood vinegar and determining the optimal concentration (18-22%) to selectively target harmful bacteria while preserving beneficial lactic acid bacteria.
M/S Bharath Chemical Industries v.The Registrar Of Trademarks
The Karnataka High Court addressed a writ petition filed by M/S Bharath Chemical Industries seeking the rectification of a trademark register. The petitioner had sought to expunge the name of another party from the registration of the mark 'BCI-BHARATHA CHEMICAL INDUSTRIES' (TM No. 2835990). However, during the preliminary hearing, the petitioner voluntarily submitted that the petition was withdrawn. Consequently, the court dismissed the case as withdrawn, while reserving all rights for the petitioner to pursue other legal remedies.
M/s. Symphony Recording Co. v.Dr.K.Shobana
The appellant (M/s. Symphony Recording Co.) appealed an order that granted interim injunctions to the respondent (Dr. K. Shobana), alleging infringement of her copyright in sound recordings ('Kanda Sashti Kavacham' and 'Twinkle Twinkle Little Star'). The core dispute revolved around whether agreements signed by Dr. Shobana while she was a minor were valid, and the rights of the performer under the Copyright Act.
Yang, Liping v.Controller Of Patents And Designs
Yang, Liping appealed an order dated November 18, 2013, which refused his Indian Patent Application (No. 2769/DELNEP/2004). The refusal was based on the patent not meeting Section 2(1)(j) of the Indian Patent Act, 1970. The court issued directions for service and filing of replies to proceed with the appeal.
M/s Rockmed Pharma Pvt. Ltd. v.M/s Nukind Healthcare & Anr.
The suit was filed under Section 27 of the Trade Mark Act against M/s Nukind Healthcare and others, alleging that they were passing off pharmaceutical products under the identical trademark 'KETOGOLD'. The plaintiff established extensive use, goodwill, and reputation of the mark. The court decreed the suit in favor of the plaintiff.
Ht Media Limited v.Entertainment Network (India) Ltd
The Delhi High Court disposed of an appeal concerning a trademark infringement suit between Ht Media Limited and Entertainment Network (India) Ltd. The original dispute centered on the use of trademarks identical or deceptively similar to 'PEHLA NASHA.' Crucially, both parties successfully reached a settlement through the court's mediation center. Consequently, the High Court decreed the underlying suit based on the terms of the executed Settlement Agreement, effectively concluding the litigation.